Because of their generally very high mutation rates in most cancers, TTN alone or other FLAGS (Shyr et al, 2014) have been suggested as potential surrogates for TMB (Jia et al, 2019; Oh et al, 2020) which is predictive in terms of responsiveness to immune checkpoint inhibitors (Rizvi et al, 2018). Here, TTN is linked to cancer.